They may also act upon peroxisome proliferator-activated receptors.

Peroxisome proliferator-activated receptor alpha has been shown to interact with:

Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?

SLC22A5 is regulated by peroxisome proliferator-activated receptor alpha.

They work by binding to the peroxisome proliferator-activated receptors (PPARs).

Pirinixic acid is a hypolipidemic, peroxisome proliferator-activated receptor agonist.

PPAR agonists are drugs which act upon the peroxisome proliferator-activated receptor.

It also helps protect the brain from oxidative stress by activating peroxisome proliferator-activated receptor gamma.

This gene is induced under hypoxic (low oxygen) conditions in various cell types and is the target of Peroxisome proliferator-activated receptors.

The main target is thought to be the peroxisome proliferator-activated receptor alpha (PPAR-α).

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) family.

Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway.

Emerging evidence shows that some phytoestrogens bind to and transactivate peroxisome proliferator-activated receptors (PPARs).

It lowers lipid levels by activating Peroxisome proliferator-activated receptor alpha (PPARα).

Farglitazar is a peroxisome proliferator-activated receptor agonist which is being developed by GlaxoSmithKline for the treatment of hepatic fibrosis.

CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter.

For example, peroxisome proliferator-activated receptor (PPAR) gamma agents are commonly used drugs to treat type 2 diabetes mellitus.

Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 is a protein that in humans is encoded by the PPRC1 gene.

Troglitazone, like the other thiazolidinediones (pioglitazone and rosiglitazone), works by activating peroxisome proliferator-activated receptors (PPARs).

Peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) is a transcriptional regulator for genes involved in mitochondrial biogenesis, fatty acid oxidation, and gluconeogenesis.

Lung cancer cells also increase DLC1 expression in response to peroxisome proliferator-activated receptor γ (PPARγ) activators.

Oleoylethanolamine (OEA) is an endogenous peroxisome proliferator-activated receptor alpha (PPAR-α) agonist.

A peroxisome proliferator-activated receptor δ (PPARδ)-mediated transcriptional pathway is involved in the regulation of the skeletal musclefiber phenotype.

Dominant-negative mutations in Peroxisome proliferator-activated receptor gamma (PPARγ) are associated with severe insulin resistance, diabetes mellitus and hypertension.